Heinzow B G, Angus J A, Korner P I
Eur J Pharmacol. 1982 Oct 22;84(3-4):177-87. doi: 10.1016/0014-2999(82)90200-x.
Alinidine (ST 567), an N-allyl derivative of clonidine, slowed the heart rate of conscious rabbits by 41 +/- 2.3 (S.E.D.) b/min and reduced mean arterial pressure (MAP) by 6.4 +/- 1.4 mmHg (P less than 0.001). The cardiac slowing was considered to be a direct effect in agreement with previous findings by others, since it was present in rabbits without functioning autonomic nerves, but the fall in blood pressure did not occur in these animals. Alinidine produced no significant changes in the reflex tachycardia response evoked by infusing nitroprusside, or in the pressure-related parameters of the MAP-heart period (HP) curve of the baroreceptor-heart rate reflex (i.e. HP range, gain, or median blood pressure BP50). Intravenous (i.v.) clonidine produced characteristic rises in baroreflex HP range and gain, which were due to vagal facilitation, and also produced falls in BP50 and resting MAP. I.v. alinidine suppressed the clonidine-induced vagal facilitation, but had no effect on the blood pressure changes. Intracisternal alinidine could be given in only relatively low dose, but reduced the clonidine-induced rise in vagal component of HP range. The main site of antagonism between i.v. alinidine and clonidine was probably in the CNS. We studied the nature of the antagonism at the sympathetic nerve terminal of the isolated left guinea pig atrium. Clonidine depressed the inotropic response to field stimulation of the sympathetic nerves and this was competitively antagonised by phentolamine greater than yohimbine greater than alinidine at potencies of about 1200:80:1. Alinidine was considered to be a weak but specific alpha 2-antagonist; it has no alpha 1-antagonist properties since it was without effect on the contractile response to noradrenaline of the guinea pig aorta. The alpha 2-antagonist property explains the suppression by alinidine of the clonidine-induced facilitation of the vagal component of the baroreceptor-heart rate reflex.
阿利尼定(ST 567)是可乐定的N-烯丙基衍生物,可使清醒家兔心率减慢41±2.3(标准误)次/分钟,平均动脉压(MAP)降低6.4±1.4 mmHg(P<0.001)。心率减慢被认为是一种直接作用,这与其他人之前的研究结果一致,因为在自主神经功能丧失的家兔中也存在这种情况,但这些动物并未出现血压下降。静脉注射硝普钠诱发的反射性心动过速反应,或压力感受器-心率反射的MAP-心动周期(HP)曲线的压力相关参数(即HP范围、增益或平均血压BP50),阿利尼定均未使其产生显著变化。静脉注射可乐定可使压力感受器反射的HP范围和增益出现特征性升高,这是由于迷走神经易化作用,同时BP50和静息MAP也会降低。静脉注射阿利尼定可抑制可乐定诱发的迷走神经易化作用,但对血压变化无影响。脑池内注射阿利尼定只能给予相对较低的剂量,但可降低可乐定诱发的HP范围迷走神经成分的升高。静脉注射阿利尼定与可乐定之间的拮抗作用主要部位可能在中枢神经系统。我们研究了在离体豚鼠左心房交感神经末梢处拮抗作用的性质。可乐定可抑制交感神经场刺激引起的变力反应,在约1200:80:1的效价下,酚妥拉明对其的竞争性拮抗作用大于育亨宾大于阿利尼定。阿利尼定被认为是一种弱但特异性的α2拮抗剂;它没有α1拮抗剂特性,因为它对豚鼠主动脉对去甲肾上腺素的收缩反应没有影响。α2拮抗剂特性解释了阿利尼定对可乐定诱发的压力感受器-心率反射迷走神经成分易化作用的抑制。